Black Diamond Therapeutics
BDTX · NASDAQ
$2.07+$0.26 (+14.36%)TodayMarket closed ·
Prev close $1.81
Who owns BDTX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 50.5% of BDTX’s shares.
- Versant Ventures10.8%
- New Enterprise Associates (NEA)7.8%
- T. Rowe Price Investment Management, Inc.7.0%
- BlackRock Institutional Trust Company, N.A.6.2%
- Next 6 largest institutions18.7%
- All other shareholders49.5%
| Holder | Shares | % of shares |
|---|---|---|
| Versant Ventures | 6.21M | 10.83% |
| New Enterprise Associates (NEA) | 4.45M | 7.76% |
| T. Rowe Price Investment Management, Inc. | 4.03M | 7.03% |
| BlackRock Institutional Trust Company, N.A. | 3.57M | 6.23% |
| Acadian Asset Management LLC | 2.35M | 4.10% |
| Vanguard Capital Management, LLC | 2.13M | 3.71% |
| Renaissance Technologies LLC | 1.96M | 3.42% |
| Defilade Capital Management, L.P. | 1.67M | 2.92% |
| Dimensional Fund Advisors, L.P. | 1.37M | 2.38% |
| Geode Capital Management, L.L.C. | 1.22M | 2.13% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| BB Biotech Fd | 2.73M | 4.77% |
| T. Rowe Price Small Cap Value Fund | 2.12M | 3.70% |
| Vanguard Total Stock Market Index Fund | 1.56M | 2.72% |
| iShares Russell 2000 ETF | 1.20M | 2.10% |
| Fidelity Enhanced Small Cap Core ETF | 599.39K | 1.05% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of BDTX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Raman Prakash | Award | 6.80K | $13.13K |
| Behbahani Ali | Award | 7.71K | $14.87K |
| Raman Prakash | Award | 7.91K | $13.13K |
| Behbahani Ali | Award | 8.96K | $14.88K |
Short interest
Settled Sep 30, 2026
- Shares short
- 4.78M
- Days to cover
- 7.31
- % of shares outstanding
- 8.33%
- Average daily volume
- 653.62K
- Change since last report
- −7.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.